摘要 |
Novel florfenicol compounds having the chemical structure: or a pharmaceutically-acceptable salt thereof or a solvate thereof, or prodrug thereof, wherein R<SUP>1 </SUP>is CHCl<SUB>2</SUB>, CHClF, CHF<SUB>2</SUB>, CHBrCl, CH<SUB>3</SUB>, CH<SUB>2</SUB>N<SUB>3</SUB>, CH<SUB>2</SUB>CN, CH(R<SUP>2</SUP>)NH<SUB>2 </SUB>or CH X<SUP>1</SUP>X<SUP>2</SUP>; where R<SUP>2 </SUP>is H, CH<SUB>3 </SUB>or CH<SUB>2</SUB>OH, and X<SUP>1 </SUP>and X<SUP>2 </SUP>are independently selected halogens; and R<SUP>3 </SUP>is CH<SUB>2</SUB>Cl, CH<SUB>2</SUB>F, CHF<SUB>2</SUB>, CHCl<SUB>2 </SUB>or CH<SUB>2</SUB>OH are disclosed. The compounds are useful for the treatment and/or prevention of bacterial infections in a broad range of patients such as, without limitation, birds, fish, shellfish and mammals.
|